SEATTLE, July 09, 2018 (GLOBE NEWSWIRE) -- The global cannabis testing market is estimated to be valued at US$ 926.3 million in 2017, and is projected to exhibit a CAGR of 13.2% over the forecast period (2018 – 2026).
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/cannabis-testing-market-170
Key Trends and Analysis of the cannabis testing market:
Legalization of the cannabis across the world for medicinal application with some allowing even recreational is propelling demand for checking quality parameters of cannabis to be used in this application. For instance, in 2017, Germany allowed medicinal use of cannabis. Moreover, 18 states of the U.S. allowed the use of Cannabidiol (CBD) extract in oil form for the treatment of epilepsy or seizures adversely affected children in 2017. Australia allowed cultivation of cannabis plant for medicinal and scientific purpose under national licensing scheme in 2016, and more recently in January 2018, Australia allowed commercial export of cannabis.
Legalization is expected to increase commercial production of cannabis and cannabis-based pharmaceutical products in market. This in turn is expected to propel demand for large number of labs to test cannabis for its potency and concentration of unwanted trace materials. Product manufacturers such as Shimadzu are introducing dedicated cannabis potency analyzer based on HPLC system (2016) which would expand user base. Furthermore, increased efforts to standardize the quality parameters for cannabis testing (cannabinoid, Terpene) is expected to drive growth of the cannabis testing market
Request Sample Copy of this Report
Key Market Takeaways:
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com